History

  • 2020's
  • 2010's
  • 2000's

2020's

2023
01

the inauguration of the new CEO"

2022
03

Market launch of new product - Viral Transport Medium (VTM)

03

Market launch of new product - Saliva DNA Collector

03

Market launch of new product - Influenza A/B Kit

09

Indonesia-Korea Future Industry Business Plaza 2022"

2021
04

Acquired ISO 13485:2016 certification

04

Completion/Opening of INSOL Logistics Center

05

Relocation of corporate headquarters

06

Market launch of Wartfreezer (cryosurgical device)

07

Created TFT for metaverse platform integration & utilization

2020
05

Selected as host organization for “Eurostars-2,” international collaborative research project sponsored by Ministry of Trade, Industry and Energy (MOTIE)

05

Selected as host organization for “Bioindustry Core Project” sponsored by Ministry of Trade, Industry and Energy (MOTIE)

09

Acquired GMP certification for IVD medical devices

2010's

2019
06

Selected as “Strong & Small Enterprise for Work-Life Balance” by City of Seoul

07

Certified as “Main Biz” (Management Innovation Business) by Ministry of SMEs and Startups (MSS)
(www.mainbiz.go.kr)

08

Acquired GMP Certificate for “Medical Device Manufacturing & Quality Management Standard Conformity”

11

Selected as participant organization for “Infectious Disease Crisis Response Technology Development” program led by Ministry of Health and Welfare (MOHW)

12

Selected as “Outstanding Enterprise for Job Creation” by Seoul Business Agency (SBA)

2018
09

Acquired business license for medical device manufacturing. Established medical device manufacturing facility.

12

Completion/Opening of INSOL GMP Factory

12

Selected as “2019 Young-Adult-Friendly Enterprise” by Ministry of Employment and Labor (MOEL)

2018
2017
09

Sponsored “Water Wells for Africa” program in Zambia

12

Business partnership agreement with Korea Basic Science Institute (KBSI)

12

Selected as “2018-2020 Small/Medium-Sized Enterprise for Talent Development” by Ministry of SMEs and Startups (MSS)

2017
2016
03

Received “The 2016 Customer-Loving Brand Award ? Grand Prize” from JoongAng Daily

12

Signed agreement with Good Neighbors International (NGO) for “Good_Buy” campaign participation

12

Certification/Opening of INSOL R&D Center

2015
04

Launched INSOL mall (insolmall.co.kr) & OraQuick brand site (oraquick.co.kr)

05

Market launch of OraQuick HIV Self-Test

11

New Health Technology (nHT) designation granted for QED A-150 by Ministry of Health and Welfare (MOHW)

2014
02

Exclusive distribution agreement with DNA Genotek (Canada)

09

Product supply agreement with Genoplan

2014
2013
07

Development of OraQuick Auto Transmission System (in collaboration with Asan Medical Center)

2013
2012
07

Sales partnership agreement with Hyundai Pharmaceutical

09

“Non-reimbursement” code published by Ministry of Health and Welfare (MOHW) for INSOL-OraQuick HCV Rapid Antibody Test

2011
03

Conducted multi-site clinical trial (local bridging study) for OraQuick HCV Rapid Antibody Test

10

New Health Technology (nHT) designation granted for OraQuick HCV Rapid Antibody Test by Ministry of Health and Welfare (MOHW)

2010
08

Completion of research project for Korea Disease Control and Prevention Agency (KDCPA)

11

Supplied Histofreezers (cryosurgical devices) to the Korean military

2000's

2008
05

New Health Technology (nHT) designation granted for OraQuick ADVANCE Rapid HIV-1/2 Antibody Test by Ministry of Health and Welfare (MOHW)

07

“Non-reimbursement” decision made by Health Insurance Review & Assessment Service (HIRA) for medical services rendered through OraQuick ADVANCE Rapid HIV-1/2 Antibody Test

07

“eSTIM” registered as official trademark by Korean Intellectual Property Office (KIPO)

2008
2007
03

Acquisition of business license for medical device import

04

Market launch of Histofreezer (cryosurgical device)

05

Market launch of OraQuick ADVANCE Rapid HIV-1/2 Antibody Test

10

Launched eSTIM program & website (www.estim.co.kr) for early testing of sexually transmitted infections (STIs)

2006
02

Exclusive distribution agreement with OraSure Technologies (USA)

02

Certification for KGSP (Korea Good Supplying Practice)

03

Market launch of GIL Thiotepa

09

MFDS regulatory approval for OraQuick ADVANCE Rapid HIV-1/2 Antibody Test

09

Business name changed to Innovative Medical Solutions Co., Ltd. (INSOL)

2005
04

Collaborative partnership agreement with C.H.A (Japan)

10

Supply agreement with Bedford Laboratories (USA)

10

MFDS regulatory approval for Thiotepa (anti-cancer chemotherapy drug)

2004
07

Global In-Licensing USA (GIL USA) established

12

Global In-Licensing Korea Co., Ltd. (GIL Korea) established